ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 78

$695K Total Retail Price of All Prescriptions

Rank: 11 out of 78

264 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 264 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 4,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $131 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 365 265 1 1
CRESTOR 299 249 2 23
ATORVASTATIN CALCIUM 240 170 3 21
SERTRALINE HCL 142 129 4 55
HUMALOG 136 81 5 11
METFORMIN HCL 133 85 6 3
LISINOPRIL 120 83 7 15
PRAVASTATIN SODIUM 111 69 8 17
NOVOLOG 111 68 8 12
SYNTHROID 103 74 10 2
INSULIN SYRINGE 101 73 11 8
LOSARTAN POTASSIUM 96 75 12 25
GABAPENTIN 94 62 13 20
PREDNISONE 90 77 14 61
AVANDIA 89 60 10 15 82
HUMALOG MIX 50-50 89 72 15 39
FUROSEMIDE 84 55 17 26
SPIRONOLACTONE 81 39 18 33
PEN NEEDLE 78 51 19 5
GLIMEPIRIDE 77 41 20 6
DESMOPRESSIN ACETATE 77 54 20 84
FLUDROCORTISONE ACETATE 72 48 22 90
JANUVIA 71 58 23 13
TRAZODONE HCL 70 49 24 94
OMEPRAZOLE 70 45 24 32
CARVEDILOL 70 62 24 47
SIMVASTATIN 68 38 27 7
AMLODIPINE BESYLATE 67 52 28 19
LANTUS 67 41 28 4
LIPITOR 62 31 30 54
HYDROCODONE-ACETAMINOPHEN 60 48 S3 31 24
METOPROLOL TARTRATE 59 24 32 40
POTASSIUM CHLORIDE 57 52 33 34
ALLOPURINOL 54 28 34 105
NOVOLOG FLEXPEN 52 51 35 14
GUANFACINE HCL 51 43 R 36 109
DILTIAZEM ER 50 42 37 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.